Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

MetaModix manufactures surgical and medical instruments for the treatment of metabolic diseases and Type II diabetes. The company's first product, the EndoSleeve, is designed to be a safer and more cost-effective treatment option for patients suffering from type 2 diabetes, NASH, and obesity. It was founded in 2009 and is headquartered in Plymouth, Minnesota, United States.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

CXR Biosciences is advancing and commercializing innovative approaches to transform the drug development and chemical safety assessment process. As well as introducing new technology platforms to the marketplace, CXR also helps customers to take their candidate compounds through development efficiently, or to resolve problems that have been encountered, through the provision of customized solutions. The company has business relationships with over sixty customers and collaborators, including pharmaceutical companies, chemical companies, biotechnology companies, leading universities and research institutions.

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

The Korea Institute of Ocean Science and Technology (KIOST) with its headquarters in Busan, South Korea, has driven development of the marine sciences and technology of Korea for almost 50 years since its establishment in 1973. Formerly known as the Korean Ocean Research and Development Institute (KORDI), it started functioning with the new name of Korea Institute of Ocean Science and Technology from July 1, 2012.

Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.

Neuron Bio SA is a biotechnological company, which engages in the research and development of areas in biotechnology. It operates through the following sectors: Neuron Biolabs and Neol Bio. The Neuron Biolabs sector develops biosolutions for application in the pharmaceutical and agri-food industries through its specialized divisions. The Neol Bio sector includes the development of innovative biotechnological, industrial microbial processes for application in different sectors: functional food, oleochemistry, bioenergy, and other bioproducts. The company was founded by Fernando Valdivieso Amate on December 19, 2005 and is headquartered in Granada, Spain.

Rosa helps clients better understand complex biology and inform their critical decisions from preclinical through clinical development with the creation and use of flexible mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. Rosa offers both PhysioPD Research Platforms and classic pharmacokinetic/pharmacodynamic (PK/PD) models. Rosa’s clients participate in customized model development and testing processes, retain the resulting models, and acquire the ability to perform simulation research to better understand implications for their pharmaceutical, consumer, and veterinary product development programs. Rosa has unparalleled experience in applying modeling and simulation to better understand biology and accelerate product development and is unique in its breadth and depth of disease area experience, including metabolic, cardiovascular, oncology, inflammation, immune dysfunction, CNS, respiratory, dermatology, nutrition, and antibacterial/antiviral biology.

Centrus International, Inc. develops rapid optical testing systems. The company was founded on February 10, 2006 and is headquartered in Lansing, MI.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

LSee is a disruptive solution to make weight loss easy. It includes a connected device that measures metabolism in real time and a mobile app that analyzes results to adapt your behavior in order to achieve your weight loss goals. With LSee, consumers can now personalize their diets and exercise routines based on their body needs to efficiently reduce body fat.

Gachon University Gil Medical Center is a South Korean private company. The firm operates as medical center.

Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.